Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

How Weak Supplier Qualification Caused Equipment Qualification Failures: A Pharma Case Study

A German pharmaceutical manufacturer asked Zamann Pharma Support to strengthen its Equipment Qualification (EQ) compliance with EMA and FDA expectations.

During the project, Zamann identified a critical weakness: the company used GMP equipment from vendors that it had not properly qualified.

Major suppliers had not undergone audits. Quality agreements did not clearly define documentation responsibilities. In addition, FAT/SAT records were incomplete, software suppliers lacked GAMP assessments, and several vendor validation packages were missing.

As a result, qualification teams faced missing records, unclear design information, repeated qualification work, and uncertain supplier responsibilities.

Weak supplier qualification had therefore become a risk across the entire Equipment Qualification lifecycle.

Our team assessed supplier risks, reviewed vendor documentation, defined qualification requirements, connected supplier evidence to the EQ lifecycle, and proposed a structured supplier requalification approach.

Challenges Faced

A detailed GAP analysis in Quality Management Systems is essential for identifying process deficiencies effectively.
  • Missing Supplier Oversight: The company had not audited several major equipment vendors. Therefore, it lacked evidence of supplier capability.
  • Undefined Responsibilities: Quality agreements did not clearly assign documentation duties. As a result, ownership of missing records remained unclear.
  • Incomplete FAT and SAT: FAT/SAT activities lacked consistent execution and documentation. This contributed to installation and OQ problems.
  • Missing Qualification Records: One supplier did not provide key installation and calibration documents. Consequently, IQ was delayed by six weeks and OQ had to be repeated.
  • Unassessed Software Suppliers: The company had not assessed some software vendors under GAMP categories. It also lacked audit-trail validation and defined cybersecurity requirements.

Zamann Pharma Support’s Approach

  • Risk-Based Supplier Assessment: Our team assessed suppliers based on equipment criticality, data integrity, software involvement, and product quality impact.
  • Quality and Technical Agreements: We defined responsibilities for FAT/SAT, qualification documents, electronic records, changes, cybersecurity, and spare parts.
  • Vendor Documentation Control: We identified the supplier records needed to support qualification, including design documents, certificates, FAT/SAT reports, and software records.
  • Integration With Equipment Qualification: We linked supplier evidence to the URS, risk assessment, test protocols, and traceability matrix.
  • Software Supplier Assessment: We included GAMP category assessment, audit-trail expectations, and software documentation requirements.
  • Supplier Requalification: We proposed periodic reviews of critical vendors every two to three years based on performance and compliance history.

Results Achieved

  • Supplier Gaps Identified: The assessment exposed weaknesses in audits, agreements, FAT/SAT records, software assessment, and vendor documentation.
  • Qualification Risks Clarified: The team connected supplier weaknesses with delayed IQ, repeated OQ, deviations, and missing records.
  • Responsibilities Defined: The proposed framework clarified supplier and company responsibilities across the equipment lifecycle.
  • Vendor Evidence Structured: Supplier documentation became linked to qualification requirements and traceability records.
  • Requalification Framework Established: The proposed model created a structured approach for periodic review of critical suppliers.
Laboratory
GMP qualification and lifecycle validation activities including IQ, OQ, and PQ supporting inspection readiness in pharmaceutical manufacturing.
Services

Qualification and Validation for GMP Systems

Our team supports the planning, execution, and maintenance of qualification and validation activities, including IQ, OQ, and PQ, to keep GMP-regulated systems compliant and under control.

Contact Us

Need help? Don't hesitate to get in touch
Zamann pharma support is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

FAQ

1. How can missing vendor documentation compromise Equipment Qualification?

Missing vendor documentation can break the evidence chain between equipment design and qualification. Without approved design specifications, installation requirements, calibration certificates, or FAT/SAT records, the qualification team may not have enough evidence to confirm correct installation or define reliable OQ tests. In this case, documentation gaps delayed IQ by six weeks and contributed to repeated OQ activities.

 

2. When does a software supplier create additional Equipment Qualification risk?

The risk increases when automated equipment includes software but the company does not assess the supplier and system under the relevant GAMP category. Gaps become more significant when teams also fail to evaluate audit trails, software configuration, electronic records, or required software documentation. As a result, the equipment may complete mechanical qualification while its computerized functions remain insufficiently assessed.

3. Which supplier records should be traceable throughout the Equipment Qualification lifecycle?

Critical supplier records should connect directly to the URS, risk assessment, qualification protocols, and traceability matrix. Depending on the equipment, this evidence can include Design Specifications, Functional Descriptions, installation requirements, calibration and material certificates, FAT/SAT reports, and software configuration records. This traceability helps the qualification team show how supplier evidence supports equipment requirements and qualification testing.